MedPath
Found 21 clinical trials|View Analysis
Sort by:

Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

Not yet recruiting
Conditions
Cirrhosis
Cirrhosis Due to Hepatitis B
Cirrhosis Due to Hepatitis C
Cirrhosis and Chronic Liver Disease
Cirrhosis of the Liver
Hepatocellular Carcinoma
First Posted Date
2024-10-26
Last Posted Date
2024-10-26
Lead Sponsor
University of Oxford
Target Recruit Count
300
Registration Number
NCT06658782

Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients with Sarcopenia

Phase 3
Conditions
Sarcopenia
Cirrhosis of the Liver
Interventions
Drug: Branched-chain amino acid
Drug: Placebo
First Posted Date
2023-11-08
Last Posted Date
2024-11-21
Lead Sponsor
Mahidol University
Target Recruit Count
86
Registration Number
NCT06121492
Locations
🇹🇭

Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, Bangkok, Thailand

Oral Health In Cirrhosis of the Liver (ORACLE)

Recruiting
Conditions
Periodontal Diseases
Cirrhosis
Interventions
Procedure: Dental exam and periodontal cleaning if needed
First Posted Date
2023-09-25
Last Posted Date
2024-04-29
Lead Sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Target Recruit Count
100
Registration Number
NCT06052150
Locations
🇺🇸

Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States

🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Composition for Treating Cirrhosis and Liver Cancer (SB-1121)

Not Applicable
Completed
Conditions
Cirrhosis of the Liver
Interventions
Drug: SB-1121(1)
Drug: SB-1121(2)
First Posted Date
2022-01-05
Last Posted Date
2024-09-30
Lead Sponsor
Nguyen Thi Trieu, MD
Target Recruit Count
134
Registration Number
NCT05178303
Locations
🇻🇳

Saigon Biopharma Company Limited, Ho Chi Minh City, Vietnam

A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

Phase 2
Completed
Conditions
Sarcopenia
Liver Cirrhosis
Interventions
Drug: Placebo
Drug: LPCN 1148
First Posted Date
2021-05-05
Last Posted Date
2024-03-15
Lead Sponsor
Lipocine Inc.
Target Recruit Count
30
Registration Number
NCT04874350
Locations
🇺🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

🇺🇸

University of Texas Southwestern, Dallas, Texas, United States

🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

and more 7 locations

Magnetic-assisted Capsule Endoscope With 3D Images in EV Detection in Cirrhotic Patient

Conditions
Esophageal Varices in Cirrhosis of the Liver
Interventions
Device: magnetic-assisted capsule endoscope system (InsightEyes EGD System) with or without 3D images
First Posted Date
2020-10-19
Last Posted Date
2020-10-19
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Target Recruit Count
140
Registration Number
NCT04588974
Locations
🇨🇳

Endoscopy Center for Diagnosis and Treatment, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention

Not Applicable
Completed
Conditions
Cirrhosis of the Liver
Sarcopenia
Frailty Syndrome
Interventions
Combination Product: Home exercise program for 12 months.
Combination Product: No specific intervention.
Combination Product: Branched-chain amino acids (BCAA)
First Posted Date
2020-01-28
Last Posted Date
2024-02-29
Lead Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Target Recruit Count
37
Registration Number
NCT04243148
Locations
🇪🇸

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Gastric Slow Wave and Autonomic Nervous Function in Cirrhotic Patients With Esophageal Varices After Ligation-A Clinical Research

Completed
Conditions
Esophageal Varices in Cirrhosis of the Liver
Interventions
Diagnostic Test: Electrogastrogram(EGG)
Diagnostic Test: Heart Rate Variability(HRV)
First Posted Date
2019-10-14
Last Posted Date
2019-10-14
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
28
Registration Number
NCT04125875
Locations
🇨🇳

First Affiliated Hospital of Nanjing Medical Universit, Nanjing, Jiangsu, China

MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease

Completed
Conditions
Liver Disease
Liver Failure
Cirrhosis of the Liver
Acute-On-Chronic Liver Failure
Interventions
Other: blood sampling for research purpose
Other: clinical data collection
Other: Health-related Questionnaires
Other: Sampling other biological materials (e.g. liver biopsies, liver resections, ascites, urine, gut biopsies)
First Posted Date
2019-10-04
Last Posted Date
2024-06-25
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
277
Registration Number
NCT04116242
Locations
🇨🇭

University Hospital Basel, Hepatology Department and Laboratory, Basel, Switzerland

🇨🇭

Cantonal Hospital St. Gallen, St. Gallen, Switzerland

🇬🇧

King's College Hospital, Institute of Liver studies, London, United Kingdom

and more 1 locations

Endoscopic Variceal Ligation in Children

Completed
Conditions
Upper Gastrointestinal Bleeding
Endoscopy
Child
Esophageal Varices in Cirrhosis of the Liver
Interventions
Drug: Non-Selective Beta-Blocking Agent
Procedure: Endoscopic Variceal Ligation
First Posted Date
2019-05-09
Last Posted Date
2019-05-09
Lead Sponsor
Hospital Vall d'Hebron
Target Recruit Count
60
Registration Number
NCT03943784
© Copyright 2025. All Rights Reserved by MedPath